First Wave BioPharma Inc. (FWBI) Financial Statements (2024 and earlier)

Company Profile

Business Address 777 YAMATO ROAD
BOCA RATON, FL 33431
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,711,7701,362,9108,248,6846,062,141175,7961,114,343
Cash and cash equivalents3,711,7701,362,9108,248,6846,062,141175,7961,114,343
Receivables  93,014 551,4892,637,3033,172,676
Prepaid expense1,244,4661,956,8311,176,2681,256,154595,187512,982
Total current assets:4,956,2363,412,7559,424,9527,869,7843,408,2864,800,001
Noncurrent Assets
Operating lease, right-of-use asset195,440259,261 74,23882,386
Property, plant and equipment14,56543,83973,11018,32977,391128,854
Intangible assets, net (including goodwill)1,684,1821,684,182 4,933,5845,293,7701,924,830
Goodwill1,684,1821,684,182 2,054,0481,886,6861,924,830
Intangible assets, net (excluding goodwill)   2,879,5363,407,084 
Deposits noncurrent assets11,25018,149    
Other noncurrent assets   2,291,914   
Other undisclosed noncurrent assets21,52221,513 27,92041,047615,710
Total noncurrent assets:1,926,9592,026,9442,365,0245,054,0715,494,5942,669,394
TOTAL ASSETS:6,883,1955,439,69911,789,97612,923,8558,902,8807,469,395
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,379,5671,040,2163,100,9841,685,6031,754,6822,070,396
Interest and dividends payable  112,543 
Employee-related liabilities   253,225
Accounts payable554,277720,0402,681,9141,685,6031,754,6822,070,396
Accrued liabilities825,290320,176419,070127,01271,177285,061
Other undisclosed accounts payable and accrued liabilities    (127,012)(183,720)(538,286)
Debt612,784603,494641,236552,4051,521,302255,032
Other liabilities4,23912,1388,092,80757,417476,224 
Due to related parties   533,428670,095
Other undisclosed current liabilities1,136,727827,639465,36113,250,000  
Total current liabilities:3,133,3172,483,48712,300,38815,545,4254,285,6362,995,523
Noncurrent Liabilities
Long-term debt and lease obligation      
Long-term debt, excluding current maturities      
Liabilities, other than long-term debt146,949214,0607,311,13819,123  
Deferred income tax liabilities     
Other liabilities   7,311,13819,123  
Operating lease, liability146,949214,060   
Total noncurrent liabilities:146,949214,0607,311,13819,123  
Total liabilities:3,280,2662,697,54719,611,52615,564,5484,285,6362,995,523
Temporary equity, carrying amount      
Equity
Equity, attributable to parent3,602,9292,742,152(7,821,550)(2,640,693)4,617,2444,473,872
Common stock1561001,4853,1152,6801,771
Additional paid in capital187,931,445171,275,741147,305,14793,834,93668,575,85153,139,259
Accumulated other comprehensive loss   (1,224,135)(1,112,546)(1,266,555)(1,150,112)
Accumulated deficit(184,328,672)(168,533,689)(153,904,047)(95,366,198)(62,694,732)(47,517,046)
Total equity:3,602,9292,742,152(7,821,550)(2,640,693)4,617,2444,473,872
TOTAL LIABILITIES AND EQUITY:6,883,1955,439,69911,789,97612,923,8558,902,8807,469,395

Income Statement (P&L) (USD)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues
(Net Investment Income)
    484  
Gross profit:    484  
Operating expenses(15,770,827)(12,678,066)(59,056,888)(26,432,768)(14,743,747)(13,221,771)
Other operating expense, net
(Other Expenses)
     (433,939) 
Other undisclosed operating loss    (484) (210,000)
Operating loss:(15,770,827)(12,678,066)(59,056,888)(26,432,768)(15,177,686)(13,431,771)
Nonoperating income (expense)(24,156)(1,951,576)519,039   
Other nonoperating expense(4,224)(232,741)(3,252)   
Interest and debt expense(22,463)(15,879)(11,235)(609,998)(433,939)(101,846)
Loss from continuing operations before equity method investments, income taxes:(15,817,446)(14,645,521)(58,549,084)(27,042,766)(15,611,625)(13,533,617)
Other undisclosed income (loss) from continuing operations before income taxes   (5,628,700)  
Loss from continuing operations before income taxes:(15,817,446)(14,645,521)(58,549,084)(32,671,466)(15,611,625)(13,533,617)
Income tax benefit      
Loss from continuing operations:(15,817,446)(14,645,521)(58,549,084)(32,671,466)(15,611,625)(13,533,617)
Loss before gain (loss) on sale of properties:(58,549,084)(32,671,466)(15,611,625)(13,533,617)
Net loss:(15,817,446)(14,645,521)(58,549,084)(32,671,466)(15,611,625)(13,533,617)
Other undisclosed net income attributable to parent22,46315,87911,235 433,939 
Net loss attributable to parent:(15,794,983)(14,629,642)(58,537,849)(32,671,466)(15,177,686)(13,533,617)
Preferred stock dividends and other adjustments(308,128)(296,127)(465,361)905,660  
Other undisclosed net loss available to common stockholders, basic  (47,300)(25,515,378)(9,966,532)  
Net loss available to common stockholders, basic:(16,103,111)(14,973,069)(84,518,588)(41,732,338)(15,177,686)(13,533,617)
Other undisclosed net income available to common stockholders, diluted      
Net loss available to common stockholders, diluted:(16,103,111)(14,973,069)(84,518,588)(41,732,338)(15,177,686)(13,533,617)

Comprehensive Income (USD)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(15,817,446)(14,645,521)(58,549,084)(32,671,466)(15,611,625)(13,533,617)
Comprehensive loss:(15,817,446)(14,645,521)(58,549,084)(32,671,466)(15,611,625)(13,533,617)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent22,4631,240,014(100,354)(154,009)317,496(194,397)
Comprehensive loss, net of tax, attributable to parent:(15,794,983)(13,405,507)(58,649,438)(32,825,475)(15,294,129)(13,728,014)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: